Clinical Trials Browser

Phase 2/3 × Gefitinib × Clear all

NCT03653546 2025-09-10

BM

Phase 2/3 Completed

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Respiratory Tract Diseases

NCT02326285 2018-01-23

NeoIntercal

Phase 2/3 Terminated

Carcinoma, Non-Small-Cell Lung

NCT00259064 2016-06-02

INSTEP

Phase 2/3 Completed

NSCLC

NCT02387086 2015-03-12

Gefitinib Combined With Thalidomide to Treat NSCLC

Phase 2/3 Unknown

NSCLC

NCT02338011 2015-01-26

EGFR

Phase 2/3 Unknown

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung